Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials

C Gallois, Q Shi, LD Pederson, T André… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE A number of studies suggest that older patients may have reduced or no benefit
from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III …

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials

C Gallois, Q Shi, LD Pederson, T André… - Journal of clinical … - pubmed.ncbi.nlm.nih.gov
Purpose A number of studies suggest that older patients may have reduced or no benefit
from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III …

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.

C Gallois, Q Shi, LD Pederson, T André… - Journal of Clinical …, 2024 - europepmc.org
Purpose A number of studies suggest that older patients may have reduced or no benefit
from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III …